Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · IEX Real-Time Price · USD
45.51
+0.39 (0.85%)
Jul 22, 2024, 9:33 AM EDT - Market open
Avidity Biosciences Employees
Avidity Biosciences had 253 employees as of December 31, 2023. The number of employees increased by 67 or 36.02% compared to the previous year.
Employees
253
Change (1Y)
67
Growth (1Y)
36.02%
Revenue / Employee
$42,964
Profits / Employee
-$903,877
Market Cap
4.35B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 253 | 67 | 36.02% |
| Dec 31, 2022 | 186 | 61 | 48.80% |
| Dec 31, 2021 | 125 | 54 | 76.06% |
| Dec 31, 2020 | 71 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Integer Holdings | 10,500 |
| RadNet | 7,872 |
| Haemonetics | 3,657 |
| Alkermes | 2,100 |
| Inspire Medical Systems | 1,011 |
| Apellis Pharmaceuticals | 702 |
| TransMedics Group | 584 |
| CRISPR Therapeutics AG | 407 |
RNA News
- 27 days ago - Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors - Business Wire
- 4 weeks ago - Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day - PRNewsWire
- 4 weeks ago - Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 5 weeks ago - Avidity Biosciences to Participate in Upcoming Investor Conference - PRNewsWire
- 5 weeks ago - Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock - PRNewsWire
- 5 weeks ago - Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock - PRNewsWire
- 5 weeks ago - Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday - Benzinga